Skip to main content
Top
Published in: Endocrine 1/2019

01-01-2019 | Endocrine Imaging

18F-FDG PET reveals an adrenocortical carcinoma in a bilateral adrenal multinodular disease

Authors: Rossella Libé, Jean-François Jazeron, Estelle Louiset, Lionel Groussin

Published in: Endocrine | Issue 1/2019

Login to get access

Excerpt

A 48-year-old man underwent an abdominal computed tomography (CT) scan for asthenia. The CT scan revealed bilateral adrenal masses. The left mass measured 47 × 27 mm with a spontaneous density (SD) of -6 Hounsfield Unit (HU), in favor of a benign adrenocortical lesion (adenoma if < 10 HU). The right adrenal presented one anterior nodule of 28 × 23 mm with a SD of −25 UH, in favor of a benign lesion and a second posterior nodule of 21 × 25 mm, with a high SD of 27 UH and an absolute washout of 55% (> 60% in case of a benign lesion), consistent with an indeterminate lesion (Fig. 1a). The patient was lost of follow-up. After 1 year, the patient was referred to our hospital for hypertension, hypokalaemia and android obesity. Hormonal investigations showed an ACTH-independent hypercortisolism (Urinary free cortisol: 373 nmol/24 h (normal values:69-248), ACTH < 2 pmol/l (normal values 2 to 13)). The CT scan showed an increase in the posterior right adrenal mass (85 × 66 mm) with multiple retroperitoneal lymph nodes. The anterior right and left adrenal masses were unchanged (Fig. 1b).
Literature
1.
go back to reference M. Fassnacht, W. Arlt, I. Bancos et al. Management of adrenal incidentalomas: European Society of Endocrinology Clinical Practice Guideline in collaboration with the European Network for the Study of Adrenal Tumors. Eur. J. Endocrinol. 175(2), G1–G34 (2016)CrossRefPubMed M. Fassnacht, W. Arlt, I. Bancos et al. Management of adrenal incidentalomas: European Society of Endocrinology Clinical Practice Guideline in collaboration with the European Network for the Study of Adrenal Tumors. Eur. J. Endocrinol. 175(2), G1–G34 (2016)CrossRefPubMed
2.
go back to reference L. Groussin, G. Bonardel, S. Silvéra et al. 18F-Fluorodeoxyglucose positron emission tomography for the diagnosis of adrenocortical tumors: a prospective study in 77 operated patients. J. Clin. Endocrinol. Metab. 945, 1713–1722 (2009)CrossRef L. Groussin, G. Bonardel, S. Silvéra et al. 18F-Fluorodeoxyglucose positron emission tomography for the diagnosis of adrenocortical tumors: a prospective study in 77 operated patients. J. Clin. Endocrinol. Metab. 945, 1713–1722 (2009)CrossRef
3.
go back to reference W. Fenske, H.U. Völker, P. Adam et al. Glucose transporter GLUT1 expression is an stage-independent predictor of clinical outcome in adrenocortical carcinoma. Endocr. Relat. Cancer 16, 919–928 (2009)CrossRefPubMed W. Fenske, H.U. Völker, P. Adam et al. Glucose transporter GLUT1 expression is an stage-independent predictor of clinical outcome in adrenocortical carcinoma. Endocr. Relat. Cancer 16, 919–928 (2009)CrossRefPubMed
Metadata
Title
18F-FDG PET reveals an adrenocortical carcinoma in a bilateral adrenal multinodular disease
Authors
Rossella Libé
Jean-François Jazeron
Estelle Louiset
Lionel Groussin
Publication date
01-01-2019
Publisher
Springer US
Published in
Endocrine / Issue 1/2019
Print ISSN: 1355-008X
Electronic ISSN: 1559-0100
DOI
https://doi.org/10.1007/s12020-018-1757-3

Other articles of this Issue 1/2019

Endocrine 1/2019 Go to the issue